
1. plos negl trop dis. 2016 dec 13;10(12):e0005177. doi:
10.1371/journal.pntd.0005177. ecollection 2016 dec.

the presence, persistence functional properties plasmodium vivax duffy
binding protein ii antibodies influenced hla class ii allelic variants.

kano fs(1), souza-silva fa(1), torres lm(1), lima ba(1), sousa tn(1), alves
jr(1), rocha rs(1)(2), fontes cj(3), sanchez ba(4), adams jh(5), brito cf(1),
pires de(1), ascher db(1)(6)(7), sell am(8), carvalho lh(1).

author information: 
(1)centro de pesquisas rené rachou/fiocruz minas, belo horizonte, minas gerais,
brazil.
(2)centro de pesquisas leônidas e maria deane/fiocruz, manaus, amazonas, brazil.
(3)faculdade de medicina, universidade federal de mato grosso, cuiabá, mato
grosso, brazil.
(4)instituto de ciências da saúde, universidade federal de mato grosso, campus
sinop, sinop, mato grosso, brazil.
(5)department global health, college public health, university south
florida, tampa, florida, united states america.
(6)department biochemistry, university cambridge, cambridge, united
kingdom.
(7)department biochemistry, university melbourne, victoria, australia.
(8)programa de pós-graduação em biociências e fisiopatologia, universidade
estadual de maringá, paraná, brazil.

background: human malaria parasite plasmodium vivax infects red blood cells
through key pathway requires interaction duffy binding protein ii 
(dbpii) receptor reticulocytes, duffy antigen/receptor for
chemokines (darc). high proportion p. vivax-exposed individuals fail to
develop antibodies inhibit dbpii-darc interaction, genetic factors 
modulate humoral immune response poorly characterized. here, we
investigate dbpii responsiveness could hla class ii-linked.
methodology/principal findings: community-based open cohort study carried
out agricultural settlement brazilian amazon, 336 unrelated
volunteers genotyped hla class ii (drb1, dqa1 dqb1 loci), 
dbpii immune responses monitored time (baseline, 6 12 months) by
conventional serology (dbpii igg elisa-detected) functional assays
(inhibition dbpii-erythrocyte binding). results demonstrated increased 
susceptibility drb1*13:01 carriers develop sustain anti-dbpii
igg response, individuals haplotype
drb1*14:02-dqa1*05:03-dqb1*03:01 persistent non-responders. hla class ii
gene polymorphisms also influenced functional properties dbpii antibodies 
(biabs, binding inhibitory antibodies), three alleles (drb1*07:01,
dqa1*02:01 dqb1*02:02) comprising single haplotype linked presence
and persistence biabs response. modelling structural effects the
hla-drb1 variants revealed number differences peptide-binding groove,
which likely lead altered antigen binding presentation profiles, and
hence may explain differences subject responses.
conclusions/significance: current study confirms heritability the
dbpii antibody response, genetic variation hla class ii genes influencing
both development persistence igg antibody responses. cellular studies 
to increase knowledge binding affinities dbpii peptides class ii
molecules linked good poor antibody responses might lead the
development strategies controlling type helper cells activated in
response dbpii.

doi: 10.1371/journal.pntd.0005177 
pmcid: pmc5154503
pmid: 27959918  [indexed medline]

conflict interest statement: authors declared competing
interests exist.

